Länder Analysen: Schweiz
| 27.03.26 | Givaudan Equal Weight | Barclays Capital | |
| 26.03.26 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 26.03.26 | Givaudan Neutral | UBS AG | |
| 26.03.26 | Zurich Insurance Hold | Deutsche Bank AG | |
| 26.03.26 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 25.03.26 | Swiss Re Neutral | UBS AG | |
| 25.03.26 | Nestlé Neutral | UBS AG | |
| 25.03.26 | Richemont Overweight | Barclays Capital | |
|
Werbung
|
|||
| 25.03.26 | Nestlé Hold | Deutsche Bank AG | |
| 24.03.26 | Nestlé Hold | Jefferies & Company Inc. | |
| 24.03.26 | Novartis Buy | Deutsche Bank AG | |
| 24.03.26 | DocMorris Sell | UBS AG | |
| 24.03.26 | Matador Secondary Private Equity Kaufen | SMC Research | |
| 24.03.26 | Givaudan Hold | Deutsche Bank AG | |
| 23.03.26 | Richemont Sector Perform | RBC Capital Markets | |
| 23.03.26 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 23.03.26 | Novartis Neutral | UBS AG | |
| 23.03.26 | DocMorris Hold | Deutsche Bank AG | |
| 23.03.26 | Richemont Overweight | JP Morgan Chase & Co. | |
| 23.03.26 | DocMorris Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.03.26 | Swiss Re Underweight | Barclays Capital | |
| 20.03.26 | Novartis Equal Weight | Barclays Capital | |
| 20.03.26 | DocMorris Hold | Deutsche Bank AG | |
| 20.03.26 | Novartis Sell | Goldman Sachs Group Inc. | |
| 19.03.26 | DocMorris Sell | UBS AG | |
| 19.03.26 | DocMorris Equal Weight | Barclays Capital | |
| 19.03.26 | DocMorris Buy | Jefferies & Company Inc. | |
| 19.03.26 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 19.03.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 18.03.26 | Nestlé Sector Perform | RBC Capital Markets | |
| 18.03.26 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 18.03.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 17.03.26 | UBS Underweight | Barclays Capital | |
| 17.03.26 | Givaudan Overweight | Barclays Capital | |
| 17.03.26 | Givaudan Neutral | UBS AG | |
| 11.03.26 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 10.03.26 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 10.03.26 | UBS Underweight | Barclays Capital | |
| 10.03.26 | Givaudan Overweight | Barclays Capital | |
| 09.03.26 | UBS Outperform | RBC Capital Markets | |
| 06.03.26 | Richemont Buy | UBS AG | |
| 06.03.26 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.03.26 | DocMorris Buy | Jefferies & Company Inc. | |
| 03.03.26 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 03.03.26 | Swiss Re Sell | Goldman Sachs Group Inc. | |
| 03.03.26 | UBS Overweight | JP Morgan Chase & Co. | |
| 02.03.26 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 02.03.26 | Swiss Re Underperform | RBC Capital Markets | |
| 27.02.26 | Swiss Re Neutral | UBS AG | |
| 27.02.26 | Swiss Re Neutral | JP Morgan Chase & Co. | |